Despite potent antiviral and antiproliferative activities, interferons have not been optimized as therapeutic agents. Chang et al. apply the power of DNA family shuffling to selectively evolve interferon genes for specific applications (p. 793). Starting from over 20 human interferon genes, they generated variants with strongly increased activity on murine cells, some of which were even more potent than native murine interferon.